Inventor
HABENER JOEL F
US23 patents
⚠️ This page may combine multiple inventors who share the name “HABENER JOEL F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GEN HOSPITAL CORP
16 patentsUS5958909ASep 28, 1999
Insulinotropic hormones and uses thereof
GEN HOSPITAL CORP116 citations99
US5118666AJun 2, 1992
Insulinotropic hormone
GEN HOSPITAL CORP446 citations99
US6849708B1Feb 1, 2005
Insulinotropic hormone and uses thereof
GEN HOSPITAL CORP141 citations97
US7138486B2Nov 21, 2006
Insulinotropic hormone derivatives and uses thereof
GEN HOSPITAL CORP78 citations96
US6866843B2Mar 15, 2005
Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
GEN HOSPITAL CORP78 citations96
US5858973AJan 12, 1999
Transcription factor and uses therefor
GEN HOSPITAL CORP53 citations96
US5614492AMar 25, 1997
Insulinotropic hormone GLP-1 (7-36) and uses thereof
GEN HOSPITAL CORP494 citations95
US6923959B2Aug 2, 2005
Method of pre-inducing a state of immune tolerance before organ transplantation
GEN HOSPITAL CORP32 citations94
US6162907ADec 19, 2000
DNA encoding insulinotropic hormone
GEN HOSPITAL CORP26 citations92
US6251667B1Jun 26, 2001
Camp-responsive transcriptional enhancer binding protein
GEN HOSPITAL CORP18 citations91
US5919649AJul 6, 1999
Camp-responsive transcriptional enhancer binding protein
GEN HOSPITAL CORP24 citations91
US6210960B1Apr 3, 2001
Nucleic acid encoding a transcription factor, IDX-1
GEN HOSPITAL CORP5 citations74
US6903073B2Jun 7, 2005
Methods to stimulate insulin production by pancreatic beta-cells
GEN HOSPITAL CORP2 citations62
US7544510B2Jun 9, 2009
Stem cells of the islets of Langerhans and their use in treating diabetes mellitus
GEN HOSPITAL CORP3 citations61
US6274310B1Aug 14, 2001
Compositions and methods for detecting pancreatic disease
GEN HOSPITAL CORP3 citations54
US7875275B2Jan 25, 2011
Use of Bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes
GEN HOSPITAL CORP0 citations45
HABENER JOEL F
3 patentsUS9040481B2May 26, 2015
Methods for treating steatotic disease
HABENER JOEL F4 citations65
US8110399B2Feb 7, 2012
Stem cells of the islets of langerhans and their use in treating diabetes mellitus
HABENER JOEL F3 citations55
US8889618B2Nov 18, 2014
C-terminal fragments of glucagon-like peptide-1 (GLP-1)
HABENER JOEL F0 citations44
MASSACHUSETTS GEN HOSPITAL
3 patentsUS7632812B2Dec 15, 2009
Methods to stimulate insulin production by pancreatic β-cells
MASSACHUSETTS GEN HOSPITAL0 citations51
US10137171B2Nov 27, 2018
Methods of treatment using a pentapeptide derived from the C-Terminus of Glucagon-Like Peptide 1 (GLP-1)
MASSACHUSETTS GEN HOSPITAL0 citations46
US10118955B2Nov 6, 2018
C-terminal fragments of glucagon-like peptide-1 (GLP-1)
MASSACHUSETTS GEN HOSPITAL0 citations46